About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Ohio | 28,737 Studies Near You

Clinical TrialsOhio

Clinical Trials in Ohio

Discover 28,737 clinical trials near Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5541-5560 of 28,737 trials

Active not recruitingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsThis is a multicenter Phase 1b, open-label study to assess safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of cabozantinib taken in combination with…NCT03170960·Gilbert, Arizona and 123 others

Find Trials by Condition in Ohio

Breast Cancerin Ohio Lung Cancerin Ohio Prostate Cancerin Ohio Colorectal Cancerin Ohio Melanomain Ohio Leukemiain Ohio Lymphomain Ohio Pancreatic Cancerin Ohio Ovarian Cancerin Ohio Brain Cancerin Ohio Diabetesin Ohio

Data from ClinicalTrials.govTerms

TerminatedA Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseThe primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on clinical decline as measured by the Integrated Alzheimer's Disease Rating Scale…NCT04619420·Birmingham, Alabama and 121 others

TerminatedLuveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AMLThis trial will evaluate whether luveltamab tazevibulin is well tolerated and active against a rare form of AML carrying a particular genetic abnormality called CBFA2T3::GLIS2…NCT06679582·Birmingham, Alabama and 35 others

Completedß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of CanakinumabThe purpose of this study was to evaluate the efficacy observed with canakinumab dose reduction in a subgroup of patients in the extension study CACZ885G2301E1.NCT02296424·Los Angeles, California and 49 others

RecruitingThe Periviable GOALS Decision Support ToolThe Periviable GOALS (Getting Optimal Alignment around Life Support) decision support tool (DST) is meant to facilitate informed shared decision-making regarding neonatal…NCT05264779·San Diego, California and 11 others

TerminatedPolyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00054184·Hoover, Alabama and 34 others

CompletedThe Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 MonthsA new drug for benign prostatic hyperplasia is used for 9 months to determine its long-term safety.NCT00224133·Birmingham, Alabama and 78 others

CompletedA Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With FibromyalgiaThis is a Phase 3, randomized, parallel-group, double-blind, placebo-controlled, 14-week study designed to evaluate the efficacy and safety of TNX-102 SL 5.6 mg (2 x 2.8 mg…NCT05273749·Phoenix, Arizona and 32 others

CompletedNovel Therapies for Resistant FSGS (FONTII): Phase II Clinical TrialThis project will test whether adalimumab,and/or galactose can safely reduce proteinuria (abnormal amounts of protein in the urine) and protect kidney function better than…NCT00814255·Miami, Florida and 17 others

CompletedSexual Orientation and Gender Identity (SOGI) Data Collection Program Implementation and EvaluationSexual and gender minority (SGM) individuals experience significant cancer-related health disparities across the cancer continuum.NCT05845476·Columbus, Ohio

Enrolling by invitationGroup Medical Appointments for Intensive Lifestyle Treatment for Obesity in Cleveland Clinic Primary Care PracticesIn 2023, Cleveland Clinic was accepted into a national program, the Patient-Centered Outcomes Research Institute Health Systems Implementation Initiative (PCORI HSII) which aims…NCT07268417·Cleveland, Ohio

CompletedStudy of Procoagulation Markers in Stroke PatientsThe Insights on Selected Procoagulation Markers and Outcomes in Stroke Trial (I-SPOT): Response to Insulin Administration and Blood Glucose Control proposal is designed to…NCT01811550·Tucson, Arizona and 37 others

RecruitingStudy to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young ChildrenThis is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their…NCT04509050·Birmingham, Alabama and 34 others

WithdrawnEffect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin TestsThis is a double-blind study with respect to the diluents used, with patients known to be allergic to the specific allergen tested.NCT01989897·Columbus, Ohio

CompletedSafety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)The overall purpose of this study is to examine the safety, tolerability, pharmacokinetics (how the body processes a drug), and activity of GS-9450 in preventing liver damage due…NCT00740610·Tucson, Arizona and 32 others

CompletedEfficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient GynecologyPain with intrauterine device (IUD) insertion is very common and there are few options for patients to help reduce this pain.NCT06335823·Cleveland, Ohio

TerminatedStudy of RO6807952 in Patients With Diabetes Mellitus Type 2This randomized, double-blind, placebo-controlled, multi-center study will evaluate the efficacy and safety of RO6807952 in patients with diabetes mellitus type 2 inadequately…NCT01516476·Cincinnati, Ohio

Active not recruitingA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)The purpose of the study is to compare Mezigdomide (CC-92480/BMS-986348) with carfilzomib and dexamethasone (MeziKD) against carfilzomib and dexamethasone (Kd) in the treatment of…NCT05552976·Mobile, Alabama and 203 others

CompletedEfficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) as maintenance treatment in participants with moderately to severely active CD who…NCT02611817·Phoenix, Arizona and 193 others

CompletedSingle Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in ChildrenThis is a multicenter trial to evaluate the single-dose safety, tolerability and pharmacokinetics-pharmacodynamics of Zolpidem in a group of children with sleep disturbances…NCT00494468·Little Rock, Arkansas and 10 others

PreviousPage 278 of 1437Next

Heart Diseasein Ohio